PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The objective of current protocol is try improve the results of chemotherapy treatment in
patients with ALL wich is not indicated the peripheral stem cell transplant in first
remission, with an intensive consolidation follow by re-inductions.